Sono-Tek (SOTK) CFO Reports 350-Share Sale at $3.33; Ownership 36,147

Rhea-AI Filing Summary

Stephen J. Bagley, CFO of Sono-Tek Corporation, reported a sale of 350 shares of common stock on 08/07/2025 at $3.33 per share. After the transaction he directly beneficially owns 36,147 shares. The Form 4 shows only this routine officer sale and lists no derivative transactions or other material changes to his ownership.

Insights

Financial Analyst

Small officer sale; immaterial to company valuation given the size relative to total holdings.

The reported sale of 350 shares at $3.33 is modest compared with the reporting person’s remaining direct stake of 36,147 shares. There are no derivative transactions disclosed, which limits complexity. From a market-impact perspective this disclosure is routine compliance and unlikely to affect SOTK trading or valuation materially.

Corporate Governance Expert

Form 4 filing reflects timely disclosure of an officer sale; governance controls appear to be functioning.

The filing identifies the reporting person as CFO and shows a direct sale coded as S for 350 shares, leaving 36,147 shares beneficially owned. The absence of 10b5-1 or derivative entries suggests this was a straightforward open-market disposition rather than a plan-based exercise. The disclosure meets Section 16 transparency expectations and presents no governance red flags.

Insider Trade Summary

Net Seller: 350 shares ($1,166)

Net Sell 1 txn

Insider Bagley Stephen James

Role CFO

Sold 350 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Sono-Tek Corp Common Stock	350	$3.33	$1K

Holdings After Transaction: Sono-Tek Corp Common Stock — 36,147 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bagley Stephen James

(Last) (First) (Middle)

SONO-TEK CORPORATION

2012 ROUTE 9W

(Street)

MILTON NY 12547

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SONO TEK CORP [ SOTK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Sono-Tek Corp Common Stock	08/07/2025		S		350	D	$3.33	36,147	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Stephen J. Bagley	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Stephen J. Bagley report for SOTK on the Form 4?

The Form 4 reports a sale of 350 shares of Sono-Tek common stock at $3.33 per share on 08/07/2025.

How many SOTK shares does the reporting person own after the transaction?

After the reported sale the reporting person directly beneficially owns 36,147 shares of Sono-Tek common stock.

What is the reporting person's role at Sono-Tek (SOTK)?

The reporting person, Stephen J. Bagley, is identified as an officer with the title CFO.

Were any derivative securities reported on this Form 4 for SOTK?

No. The filing contains no entries in Table II for derivative securities; only the non-derivative common stock sale is reported.

Does the Form 4 indicate a 10b5-1 plan or deemed execution date for the sale?

The Form 4 does not indicate a 10b5-1 plan or any deemed execution date for the reported sale.